ESMO25 & SABCS25 will dramatically reshape breast cancer treatment. We’re preparing an outstanding program for Miami Breast 2026 (March 5-8) to unpack the impact of these upcoming paradigm shifts. Don’t miss it: free registration using the code TARANTINO! https://t.co/MT57htdV1M
SG is a highly effective ADCs, and when used adequately, it saves lives. This includes careful management of toxicities, with prophylaxis when indicated. In this article we review the data & provide RW perspectives on the management of toxicities with SG. https://t.co/ACUZovlVS6
Release of DeepVariant 1.8. Large speed improvement (~67% faster) via small model for easy sites. New Pangenome-aware option. Reduces error by ~30% for vg-mapped WGS ~10% for BWA WGS ~5% BWA exome. New config for custom model users, see release notes 1/3
https://t.co/TQmQElqAOR
#Genomics is revolutionising how we understand #GeneticMaterial, offering incredible insights into how genes 🧬 function and interact. This session will explore how combining data from multiple #Biological layers—genomics, proteomics, #Metabolomics, and more—is unlocking new breakthroughs💫
✨ Davide Gianni, Senior Director Functional Genomics in Discovery Sciences, #BioPharmaceuticals R&D, @AstraZeneca
✨ Debora Lucarelli, Chief Technology Officer, @tagomics
✨ @perman_jorayev, Ph.D., Investor, @AmadeusCapital
✨ Frances Stocks Allen, Partner, @CooleyLLP
✨@GenomeRIK, CEO, @WobbleGenomics
#TechBio #TechBioUK #biotech
At TechBio UK 2024, we're diving deeper into the future of healthcare with our #Genomics Track: 'Beyond genomics – delivering on applications of #Multiomics.' 🚀 ➡ https://t.co/MmxXfoREs2
This session will explore how combining data from multiple #Biological layers—genomics, proteomics, #Metabolomics, and more—is unlocking new breakthroughs. 💫
📌 Davide Gianni, Senior Director Functional Genomics in Discovery Sciences, #BioPharmaceuticals R&D, @AstraZeneca
📌 Debora Lucarelli, Chief Technology Officer, @tagomics
📌 @perman_jorayev, Ph.D., Investor, @AmadeusCapital
📌 Frances Stocks Allen, Partner, @CooleyLLP
📌 @GenomeRIK, CEO, @WobbleGenomics
Special thanks to our headline supporter
@EliLillyandCo and event supporters @ASTRAZENECAUK, @awscloud, @Citeline, @CooleyLLP, @HSBCInnovation, @JNJNews and @lifearc1
👏
#TechBio #TechBioUK #Biotech
This year’s medicine laureates Victor Ambros and Gary Ruvkun studied a relatively unassuming 1 mm long roundworm, C. elegans.
Despite its small size, C. elegans possesses many specialised cell types such as nerve and muscle cells also found in larger, more complex animals, making it a useful model for investigating how tissues develop and mature in multicellular organisms.
Read how the 2024 medicine laureates’ investigations into C. elegans revealed an entirely new dimension to gene regulation: https://t.co/8RwUplwYQA
#NobelPrize
BREAKING NEWS
The 2024 #NobelPrize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.
@coregenomics @ambulanzen I'm also struggling with this. Feels like the scientific community just scattered and now there isn't a unified place to communicate. I'm not sure boycotting the platform has done anything other than make it harder for the community to share ideas.
Use of 26 @PacBio Iso-Seq cell line data to build a RNA foundation model LoRNA to predict transcriptome architecture, including isoform abundance, exonic structures, and variant pathogenicity. #bioinformatics
https://t.co/yBETpvOFyq
We've updated the @PacBio Kinnex single-cell RNA SMRT Link v13.1 troubleshooting guide to cover what are the metrics you should expect and how to analyze not officially tested kits such as GEM-X. #bioinformatics
https://t.co/LCugcJHrRu